SunTerra Capital
Overview
SunTerra Capital is a venture capital firm founded in 2016 and based in Shanghai, China. The firm's core business is investing in overseas companies with advanced technology, particularly in biotechnology, to promote their commercialization and development in the Chinese market. Its investment sectors include Life Sciences, Environment Tech, and Energy Tech. The firm is noted for leading the Series A funding round for EXUMA Biotech and for its investment in BioAtla, which later went public.
Portfolio Companies
1
Website
sunterra-capital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| EXUMA Biotech | Jan 2018 | VC Round | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is SunTerra Capital based?
SunTerra Capital is headquartered in Shanghai, Shanghai, China.
When was SunTerra Capital founded?
Founding year information for SunTerra Capital is not publicly available.
How many portfolio companies does SunTerra Capital have?
SunTerra Capital has 1 portfolio company in Caplight's dataset.
What are some companies in SunTerra Capital's portfolio?
Portfolio companies visible on Caplight include EXUMA Biotech.
What was SunTerra Capital's most recent investment shown here?
SunTerra Capital's most recent investment in this portfolio sample was in EXUMA Biotech in 2018.
What sectors does SunTerra Capital focus on?
SunTerra Capital focuses on Healthcare & Life Sciences.
What company stages does SunTerra Capital focus on?
SunTerra Capital typically invests at the Early stage.